L Catterton Asia aims to help Chinese online luxury goods retailer Secoo expand its frontiers with technological and logistical support from e-commerce giant JD.com
L Catterton Asia and Chinese online retailer JD.com have agreed to invest $175 million in Secoo, a Chinese e-commerce platform for luxury goods that is listed in the US.
Vivo Capital and Advantech Capital have committed $86.73 million to Chinese biopharmaceutical player Sinovac Biotech. Both investors were members of a consortium that was bidding to privatize the US-listed company, but that process has been terminated.
Ant Financial, Alibaba Group’s financial services affiliate, has led a RMB2.1 billion ($321 million) investment in Youon Bike, the listed parent of China-based bike-sharing operator Hellobike.
Hony Capital has agreed to sell three private hospitals in Zhejiang province to Hospital Corporation of China (HCC), a Hong Kong-listed platform it established several years ago, for RMB630 million ($98 million).
A private equity fund backed by China’s State Development & Investment Corporation (SDIC) is the largest strategic investor in the RMB27.1 billion ($4.3 billion) Shanghai IPO of a Foxconn Technology Group manufacturing unit.
DCP Capital Partners, a private equity firm established by the former China heads of KKR, has agreed to jointly invest $70 million alongside CDH Investments in Chinese energy industry supplier Sunpower.
L Catterton Asia will purchase an approximately 10% stake in India-listed integrated fashion retailer Future Lifestyle Fashion (FLF) for INR8.5 billion ($125 million) through newly issued shares and secondary purchases.
A healthcare fund managed by China Everbright has agreed to acquire the bulk of global medical equipment manufacturer Medtronic’s stake in Hong Kong-listed LifeTech Scientific Corporation.
Private equity-backed Sunlands Online Education ended its first day of trading on the New York Stock Exchange marginally below its IPO price following a $149.5 million offering.
Sailing Capital has invested $30.6 million in Cellular Biomedicine Group (CBMG), a China and US-based biopharmaceutical company focused on immunotherapy cancer treatments.
Creador has completed its first investment in Vietnam, committing VND994 billion ($43.8 million) to Mobile World, the country’s leading mobile device and consumer electronics retailer.
KKR has joined a group of investors including Singapore’s GIC Private and the Ontario Municipal Employees Retirement System (OMERS) to commit INR111 billion ($1.75 billion) to listed Indian financial institution HDFC.
CITIC Capital has increased its stake in Harbin Pharmaceutical Group to 60.86%, becoming the controlling shareholder of the Chinese state-backed business in which it has been an investor since 2005.
State-backed private equity investor China Integrated Circuit Industry Investment Fund (IC Fund) has agreed to buy an approximately 19% stake in domestic computer chip maker Hua Hong Semiconductor for $400 million.
OrbiMed has invested a further $7.5 million in the active pharmaceutical ingredient (API) unit of India-listed drug maker Vivimed Labs.
Hony Capital has agreed to invest in several businesses – covering furniture, beauty, and apparel – from Hong Kong conglomerate Li & Fung for $1.1 billion.
Creador has invested INR2.15 billion ($32.9 million) in Ujjivan Financial Services, the publicly listed holding company for Ujjivan Small Finance Bank.
Bain Capital Private Equity will invest INR68.5 billion ($1.05 billion) in India’s Axis Bank through a combination of equity shares and warrants that – on conversion – will give it a 4.87% stake.
Standard Chartered Private Equity (SCPE) has offered to buy a stake of unspecified size in Tat Hong Holdings in a deal that values the Singapore-listed crane and heavy equipment supplier at approximately S$376 ($277 million).
KKR has paid around $74 million for a 12.64% stake in Nippon Indosari Corpindo, an Indonesian bakery business backed by local conglomerate Salim Group and best known for the Sari Roti brand.
Shaw Kwei & Partners has agreed to acquire a 75.6% stake in Singapore-listed oil and gas industry equipment supplier Gaylin for $68 million ($50 million).
Healthcare specialist investor OrbiMed has committed $42.5 million in Uquifa, the active pharmaceutical ingredient (API) unit of India-listed pharmaceuticals business Vivimed Labs.
Singapore-based Dymon Asia Private Equity has agreed to acquire a 13% stake in Malaysia-based and Myanmar-listed bottled water producer Spritzer for about MYR63 million ($15 million).